Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Neoadjuvant/Adjuvant Cemiplimab for High Risk Cutaneous Squamous Cell Carcinoma

NCT04428671 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT04428671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04428671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Neoadjuvant/Adjuvant Cemiplimab for High Risk Cutaneous Squamous Cell Carcinoma
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
May 15, 2020
Completion date
October 1, 2031
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic skin squamous cell carcinoma, recurrent skin squamous cell carcinoma